We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

NVTA Invitae Corporation

0.0125 (1.99%)
Pre Market
Last Updated: 07:41:36
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Company Name Stock Ticker Symbol Market Type
Invitae Corporation NVTA NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0125 1.99% 0.6399 07:41:36
Open Price Low Price High Price Close Price Prev Close
more quote information »

Recent News

Date Time Source Heading
9/27/202316:29EDGAR2Form 8-K - Current report
9/25/202318:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/25/202316:30PRNUSInvitae Announces Appointment of Finance Veteran Ana Schrank..
9/22/202317:02EDGAR2Form 8-K - Current report
9/22/202316:30PRNUSInvitae Receives Notice of Non-Compliance with NYSE Minimum..
9/14/202317:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/28/202316:02PRNUSInvitae Hires Industry Veteran Robert Guigley as Chief..
8/23/202308:12EDGAR2Form 8-K - Current report
8/15/202307:30PRNUSClinical Trial Results Support Genetic Testing of All..
8/14/202316:02PRNUSInvitae Announces Selection of Finance Executive Robert..
8/10/202316:03EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
8/10/202316:01EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
8/10/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
8/09/202309:22EDGAR2Form POS AM - Post-Effective amendments for registration..
8/09/202309:20EDGAR2Form POS AM - Post-Effective amendments for registration..
8/08/202316:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:09EDGAR2Form 8-K - Current report
8/08/202316:01PRNUSInvitae Reports Second Quarter 2023 Financial Results
7/26/202316:01PRNUSInvitae to Announce Second Quarter 2023 Financial Results on..
7/05/202316:53EDGAR2Form 8-K - Current report
5/31/202306:59PRNUSInvitae to Present at the William Blair 43rd Annual Growth..
5/26/202308:01PRNUSNew Research Insights to be Presented by Invitae at the 2023..
5/25/202319:00PRNUSInvitae Announces CFO Transition and Selection of Veteran..
5/15/202316:07PRNUSInvitae to Appeal Trial Verdict
5/09/202316:01PRNUSInvitae Reports First Quarter 2023 Financial Results
4/26/202306:59PRNUSInvitae to Announce First Quarter 2023 Financial Results on..
4/17/202316:30PRNUSInvitae Publishes Annual Environmental, Social and..
4/13/202308:45PRNUSNew Study Findings Published in Nature Show Circulating..
3/22/202307:30PRNUSInvitae and Deerfield Management Partner to Create Novel..
3/21/202307:30PRNUSInvitae Announces Partnership with Epic to Streamline..
3/16/202307:30PRNUSInvitae Appoints Dr. W. Michael Korn as Chief Medical..
3/15/202317:30PRNUSInvitae to Present Data at The American Clinical Genetics..
3/06/202307:30PRNUSInvitae's PCM Assay for Minimal Residual Disease Receives..
3/01/202316:05PRNUSInvitae to Present at the TD Cowen 43rd Annual Health Care..
2/28/202316:15PRNUSInvitae Announces Convertible Notes and Share Exchange and..
2/28/202316:10PRNUSInvitae Reports Fourth Quarter and Full Year 2022 Financial..
2/14/202307:00PRNUSInvitae to Announce Fourth Quarter and Full Year 2022..
1/30/202307:30PRNUSInvitae Appoints William H. Osborne to its Board of..
1/09/202307:00PRNUSInvitae Reports Preliminary 2022 Financial Results
1/04/202307:30PRNUSInvitae to Present at the 41st Annual J.P. Morgan Healthcare..
12/20/202207:30PRNUSInvitae Completes Selected Assets Sale of its Next..
12/19/202217:15PRNUSInvitae Executive Appointed to National Health Information..
12/07/202207:30PRNUSInvitae Releases Data Use Transparency Report, Demonstrating..
12/01/202207:30PRNUSInvitae Launches Rare Patient Network for Pediatric Patients..
11/10/202210:13PRNUSInvitae Showcases Advances in Medical Genomics at the..
11/09/202207:37TRMNInvitae (NVTA) Receives a Hold from SVB Securities
11/08/202216:05PRNUSInvitae Reports Third Quarter 2022 Financial Results
10/31/202217:13PRNUSInvitae study shows therapy informed by genetic testing..
10/28/202211:16PRNUSInvitae to Present Data at the American Society of Human..
10/27/202207:30PRNUSInvitae Announces Partnership for Real-World Data Sharing to..
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: D: 20230928 11:57:04